DIFFERENTIAL EFFECT OF INTRASTRIATAL KAINIC ACID ON THE MODULATION OF DOPAMINE RELEASE BY MU-OPIOID AND DELTA-OPIOID PEPTIDES - A MICRODIALYSIS STUDY

The present study investigated the effects of a striatal lesion induced by kainic acid on the striatal modulation of dopamine (DA) release by mu- and delta-opioid peptides. The effects of [D-Pen2,D-Pen5]-enkephalin (DPDPE) and [D-Ala2, N-Me-Phe4,Gly5-ol]-enkephalin (DAGO), two highly selective delta- and mu-opioid agonists, respectively, were studied by microdialysis in anesthetized rats. In control animals both opioid peptides, administered locally, significantly increased DA levels. The effects of DPDPE were also observed in animals whose striatum had been previously lesioned with kainic acid. In contrast to the effects of the delta-agonist, the significant increase induced by DAGO was no longer observed in lesioned animals. These results suggest that delta-opioid receptors modulating the striatal DA release, in contrast to mu-receptors, are not located on neurons that may be lesioned by kainic acid.